EU medicines regulator adds stroke warning to AstraZeneca

“Cerebrovascular and sinus thrombosis (CVST) without thrombocytopenia has been reported very rarely after Vaxzevria vaccination,” the update reads.

According to the European Medicines Agency, 458 cases in which vaccinated people developed a stroke followed by cerebral haemorrhage were detected by 30 September. The majority of cases occurred during the first four weeks of vaccination. Some cases were fatal.

The agency said CVST should be added to product information as a side effect of “unknown frequency.” Blood clots that form in the brain when the platelet count is low were listed as a “very rare” side effect of the vaccine in April.

Source: ANI / Sputnik

# COVID-19

Source: The Nordic Page





Related Posts